Physical Co-morbidity, Poor Health Behaviour and Health Promotion in Verona Patients With Functional Psychoses (PHYSICO-DSM-VR)

June 22, 2016 updated by: Lorenzo Burti, Azienda ULSS di Verona e Provincia

PHYSICO-DSM-VR - Physical Co-morbidity, Poor Health Behaviour and Health Promotion in Verona Patients With Functional Psychoses: a Prevalence Study and a Randomised Controlled Study

The study evaluates the efficacy of health promotion strategies on diet and physical activity in patients with psychosis. Half of the participants will receive an intervention protocol based on education and behavioural change, while half will not receive it.

Study Overview

Status

Completed

Detailed Description

Epidemiological studies investigating the mortality and physical health of mental patients have provided substantial evidence of an excess mortality and of a substantially higher prevalence of physical co-morbidity as compared to the general population. These findings have been related to a higher prevalence of risk factors like high blood pressure, high plasma cholesterol and obesity, unhealthy lifestyles, medication side-effects.

The number of clinical trials and intervention studies in this area is still scanty and their scientific strength is relatively modest. The present research project aims at implementing preventive strategies related to dietary habits and physical exercise, and studying their efficacy with a randomized controlled study.

Study Type

Interventional

Enrollment (Actual)

325

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Verona, Italy, 37126
        • UOC 1° Servizio Psichiatria - ULSS 20
      • Verona, Italy, 37126
        • UOC 2° Servizio Psichiatria - ULSS 20
      • Verona, Italy, 37134
        • UOC 3° Servizio Psichiatria - ULSS 20
    • Verona
      • San Bonifacio, Verona, Italy, 37047
        • UOC 4° Servizio Psichiatria - ULSS 20

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • ICD-10 diagnosis of affective or non-affective functional psychosis (codes F20-22, F24, F25, F28-F31, F23.3, F33.3)
  • one or more contacts with the CMHS in the 3 months preceding the beginning of the recruitment
  • Age 18-65

Exclusion Criteria:

  • moderate or severe mental handicap (learning disability)
  • organic brain disorders
  • lack of capacity to consent to inclusion
  • subjects already involved in individual treatment related to diet and physical exercise
  • subjects deemed unable or unfit to participate in the proposed physical activities

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Intervention
"Health Promotion Intervention" package including elements of psychoeducation on healthy lifestyles and practical sessions of physical activity, with the use of motivational techniques.

The intervention package consists of the following elements:

i. educational sessions on the importance of diet and fitness; ii. motivational interviews to maintain participants in the program, to discuss participants' physical conditions, habits and opinions as to diet and fitness; iii. monitoring the participation in the program and health behaviour, specifically for diet and fitness, and adherence to the intervention on diet and fitness; iv. regular physical exercise under the guide and supervision of an expert trainer.

NO_INTERVENTION: Control
Control subjects receive treatment as usual at the Community Mental Health Services of the Department of Mental Health.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in the number of participants that comply with WHO recommendations on diet and/or exercise
Time Frame: baseline, month 1, month 2, month 3, month 4, month 5 and month 6
Following the criteria proposed by World Health Organization for a healthy lifestyle: at least 5 servings of fruit/vegetables per day and at least 30 minutes of moderate physical activity per day 5 days a week. Achieving at least one more criterion than baseline at follow up is considered a success.
baseline, month 1, month 2, month 3, month 4, month 5 and month 6

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physical examination
Time Frame: baseline
Physical examination by psychiatrist
baseline
Long term chronic disease inventory (items 2.1-2.24; MOD.ISTAT/IMF-8/B.04-05-ISTAT)
Time Frame: baseline
Questionnaire assessing chronic diseases, administered by investigators
baseline
Change in blood pressure
Time Frame: baseline, month 1, month 2, month 3, month 4, month 5 and month 6
baseline, month 1, month 2, month 3, month 4, month 5 and month 6
Change in pulses
Time Frame: baseline, month 1, month 2, month 3, month 4, month 5 and month 6
baseline, month 1, month 2, month 3, month 4, month 5 and month 6
Change in Body Mass Index
Time Frame: baseline, month 1, month 2, month 3, month 4, month 5 and month 6
baseline, month 1, month 2, month 3, month 4, month 5 and month 6
Change in waist circumference
Time Frame: baseline, month 1, month 2, month 3, month 4, month 5 and month 6
baseline, month 1, month 2, month 3, month 4, month 5 and month 6
Change in glycemia
Time Frame: baseline and month 6
baseline and month 6
Change in haemoglobin A1C
Time Frame: baseline and month 6
baseline and month 6
Change in LDL cholesterol
Time Frame: baseline and month 6
baseline and month 6
Change in HDL cholesterol
Time Frame: baseline and month 6
baseline and month 6
Change in triglyceridemia
Time Frame: baseline and month 6
baseline and month 6
Electrocardiogram
Time Frame: baseline
baseline
Medication History Schedule
Time Frame: baseline
Ad hoc form filled in by psychiatrist on present and previous psychopharmacological or non psychopharmacological medications taken by the participant
baseline
36 Item Short Form Health Survey
Time Frame: beginning and month 6
beginning and month 6
Verona Service Satisfaction Scale - European Version
Time Frame: beginning and month 6
beginning and month 6

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lorenzo Burti, Professor, Universita di Verona

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2012

Primary Completion (ACTUAL)

January 1, 2014

Study Completion (ACTUAL)

March 1, 2014

Study Registration Dates

First Submitted

May 30, 2016

First Submitted That Met QC Criteria

June 16, 2016

First Posted (ESTIMATE)

June 21, 2016

Study Record Updates

Last Update Posted (ESTIMATE)

June 23, 2016

Last Update Submitted That Met QC Criteria

June 22, 2016

Last Verified

June 1, 2016

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Psychotic Disorders

Clinical Trials on Health Promotion Intervention

3
Subscribe